The histone variant H2A.Z regulates sex differences in Alzheimer's disease pathophysiology.

H2A.Z occupancy changes in the hippocampus are sex-specific in AD, decreasing in females and increasing in males, affecting disease outcomes.

• Why it matters: Understanding sex differences in AD is crucial because women are disproportionately affected, and current mechanisms remain unclear, hindering targeted therapies.
• What they did: The study examined postmortem human hippocampus and 5xFAD mice, revealing sex-dependent alterations in H2A.Z occupancy and effects of H2A.Z.1 depletion on memory and pathology across disease stages.
• The result: H2A.Z acts as a sex- and stage-dependent regulator of AD, suggesting that chromatin-targeted therapies may need to be tailored based on sex and disease progression.